Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Non Operating Income (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Non Operating Income for 16 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 184.0% to -$1.9 million in Q4 2025 year-over-year; TTM through Nov 2025 was -$2.8 million, a 353.0% decrease, with the full-year FY2025 number at -$2.8 million, down 316.99% from a year prior.
  • Non Operating Income was -$1.9 million for Q4 2025 at Cryo Cell International, down from $17565.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $93530.0 in Q4 2023 to a low of -$1.9 million in Q4 2025.
  • A 5-year average of -$254426.2 and a median of $24.5 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: crashed 2943608.33% in 2022, then surged 13988.89% in 2023.
  • Cryo Cell International's Non Operating Income stood at $24.0 in 2021, then plummeted by 2943608.33% to -$706442.0 in 2022, then soared by 113.24% to $93530.0 in 2023, then plummeted by 824.2% to -$677344.0 in 2024, then plummeted by 184.0% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Non Operating Income are -$1.9 million (Q4 2025), $17565.0 (Q3 2025), and -$917531.0 (Q2 2025).